Electronics Health Company ProteanTecs Emerges From Stealth With a $35 Million Investment
ProteanTecs develops technology for predicting failures in electronic systems. The company was founded by three co-founders of Israeli chipmaker Mellanox
Electronics’ health prediction startup ProteanTecs Ltd. has emerged from stealth Monday to announce the completion of a $35 million series B investment round. Intel Capital, Mitsubishi UFJ Capital Co. Ltd., WRVI Capital, Israeli entrepreneur Avigdor Willenz, ITI Venture Capital Partners, Redline Capital Management SA, and Viola Ventures are among the investors who participated in the round. ProteanTecs has raised $50 million to date, according to company statements.
For daily updates, subscribe to our newsletter by clicking here.
ProteanTecs develops technology for predicting failures in electronic systems. The company was founded in 2017 by Israeli tech industry veterans Shai Cohen, Evelyn Landman, Roni Ashuri, and Raanan Gewirtzman. The company is headquartered in Haifa, with offices in New Jersey and San Francisco.